Plain-English translation of NCT07902375 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to find new biological markers (special patterns in cells) that can help detect gynecological cancers—like ovarian, endometrial, vulvar, and vaginal cancers—much earlier than current methods allow. This study asks participants to provide easy-to-collect samples at home (urine and a vaginal swab) along with a blood sample and cervical or vulvar sample at the hospital, so scientists can study whether these samples can reveal cancer earlier and help doctors catch the disease when treatment is most effective.
Unlike cervical cancer, most gynecological cancers don't have good screening programs to catch them early. Current detection methods are often uncomfortable or not accurate enough. This trial aims to find simpler, less invasive ways to identify these cancers sooner, when patients have better chances of successful treatment.
You likely qualify if…
You likely don't qualify if…
You'll collect a urine sample and vaginal swab at home the day before or day of your hospital visit, then bring them with you. At the hospital, a clinician will collect a blood sample and a cervical or vulvar sample. If tissue samples are already being taken as part of your normal care, those will be used too—the study doesn't require any extra invasive procedures. Researchers will also ask you questions about your health history and your experience with the home sampling methods. All samples are collected before any cancer treatment begins.
AI-generated summary from trial data · Oct 28, 2026 · Not medical advice
Belgium